Benefit of rituximab combined to ACVBP (R-ACVBP) over ACVBP in 209 poor- risk BDLC NHL patients treated with up-front consolidative autotransplantation: A GELA phase II trial (LNH 2003–3)

N. Mounier,C. Gisselbrecht,Olivier Fitoussi,K. Belhadj,P. Feugier,B. Coiffier,H. Tilly,O. Casasnovas,Christophe Fermé,Josette Brière,C. Haioun

Benefit of rituximab combined to ACVBP (R-ACVBP) over ACVBP in 209 poor- risk BDLC NHL patients treated with up-front consolidative autotransplantation: A GELA phase II trial (LNH 2003–3)

2009

N. Mounier
C. Gisselbrecht
Olivier Fitoussi
K. Belhadj
P. Feugier
B. Coiffier
H. Tilly
O. Casasnovas
Christophe Fermé
Josette Brière
C. Haioun

8507 Background: Rituximab (R) combined with CHOP improves survival in DLBCL pts. More intensive regimen followed by auto transplantation have been used in patients 1). CR rate after induction was...

Keywords:

Physical therapy
Regimen
Rituximab
Autotransplantation
Transplantation
CHOP
Surgery
Medicine
in patient
poor risk

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations